ATE400309T1 - Verfahren zur eliminierung von potentiell toxischen und/oder schädlichen stoffen - Google Patents

Verfahren zur eliminierung von potentiell toxischen und/oder schädlichen stoffen

Info

Publication number
ATE400309T1
ATE400309T1 AT02759794T AT02759794T ATE400309T1 AT E400309 T1 ATE400309 T1 AT E400309T1 AT 02759794 T AT02759794 T AT 02759794T AT 02759794 T AT02759794 T AT 02759794T AT E400309 T1 ATE400309 T1 AT E400309T1
Authority
AT
Austria
Prior art keywords
harmful substances
potentially toxic
eliminating potentially
toxic
eliminating
Prior art date
Application number
AT02759794T
Other languages
English (en)
Inventor
Gerhard Puetz
Juergen Eckes
Original Assignee
Eckes Dr Juergen
Puetz Dr Gerhard
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eckes Dr Juergen, Puetz Dr Gerhard filed Critical Eckes Dr Juergen
Application granted granted Critical
Publication of ATE400309T1 publication Critical patent/ATE400309T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3679—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by absorption
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/3472—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate
    • A61M1/3482—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate by filtrating the filtrate using another cross-flow filter, e.g. a membrane filter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
    • A61M1/3472—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate
    • A61M1/3486—Biological, chemical treatment, e.g. chemical precipitation; treatment by absorbents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/362—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits changing physical properties of target cells by binding them to added particles to facilitate their subsequent separation from other cells, e.g. immunoaffinity

Landscapes

  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Cardiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dispersion Chemistry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • External Artificial Organs (AREA)
  • Paper (AREA)
AT02759794T 2001-04-05 2002-04-05 Verfahren zur eliminierung von potentiell toxischen und/oder schädlichen stoffen ATE400309T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10117043A DE10117043A1 (de) 2001-04-05 2001-04-05 Verfahren zur Eliminierung von potentiell toxischen und/oder schädlichen Stoffen

Publications (1)

Publication Number Publication Date
ATE400309T1 true ATE400309T1 (de) 2008-07-15

Family

ID=7680538

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02759794T ATE400309T1 (de) 2001-04-05 2002-04-05 Verfahren zur eliminierung von potentiell toxischen und/oder schädlichen stoffen

Country Status (6)

Country Link
US (2) US20040115278A1 (de)
EP (1) EP1372758B1 (de)
AT (1) ATE400309T1 (de)
CA (1) CA2443237C (de)
DE (2) DE10117043A1 (de)
WO (1) WO2002081006A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5079506B2 (ja) * 2004-07-30 2012-11-21 プルリセレクト ゲーエムベーハー 動物についての、バイオテクノロジー（生物学的研究を含む）および医学的診断での適用のための、細胞、生体粒子および／または分子を液体から単離するための装置ならびに方法
CA2630823C (en) 2005-12-13 2015-02-10 Exthera Ab Method for extracorporeal removal of a pathogenic microbe, an inflammatory cell or an inflammatory protein from blood
JP5925693B2 (ja) 2009-12-01 2016-05-25 エクステラ・メディカル・コーポレーション 表面固定した多糖類を用いた、血液からのサイトカイン除去法
US8969322B2 (en) 2010-05-14 2015-03-03 Beth Israel Deconess Medical Center, Inc. Extracorporeal devices and methods of treating complications of pregnancy
WO2012112724A1 (en) 2011-02-15 2012-08-23 Exthera Medical, Llc Device and method for removal of blood-borne pathogens, toxins and inflammatory cytokines
US8764695B2 (en) * 2012-09-28 2014-07-01 Isaac Eliaz Reduction of galectin-3 levels by plasmapheresis
US20150004219A1 (en) * 2012-02-02 2015-01-01 Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. Stable liposomes for drug delivery
EP2861273B1 (de) 2012-06-13 2017-08-23 ExThera Medical Corporation Verwendung von heparin und kohlenhydraten zur behandlung von krebs
EP2695606A1 (de) 2012-08-09 2014-02-12 ETH Zürich Liposomenzusammensetzung für Peritonealdialyse
EP3620218A1 (de) 2013-06-24 2020-03-11 ExThera Medical Corporation Blutfiltrationssystem mit mannose beschichtetem substrat
AU2014346668C1 (en) 2013-11-08 2018-04-26 Exthera Medical Corporation Methods for diagnosing infectious diseases using adsorption media
CN106255520B (zh) 2014-04-24 2022-08-12 艾克塞拉医疗公司 使用高流速从血液除去细菌的方法
WO2016048901A1 (en) 2014-09-22 2016-03-31 Exthera Medical Corporation Wearable hemoperfusion device
ITUB20160013A1 (it) * 2016-01-27 2017-07-27 Bellco Srl Filtro per la depurazione del sangue.
WO2017151797A1 (en) 2016-03-02 2017-09-08 Exthera Medical Corporation Method for treating drug intoxication
US11911551B2 (en) 2016-03-02 2024-02-27 Exthera Medical Corporation Method for treating drug intoxication
FR3051674B1 (fr) * 2016-05-31 2019-11-08 Universite De Bourgogne Lipoproteines chargees en complexes de platine pour le traitement du cancer
EP3969014A4 (de) 2019-05-16 2023-01-25 ExThera Medical Corporation Verfahren zur modulation der endothelialen glycocalyxstruktur
CN119630438A (zh) * 2022-08-12 2025-03-14 五眼高新技术株式会社 溶剂中抗原回收系统及溶剂中抗原回收方法

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4643718A (en) * 1983-02-22 1987-02-17 Applied Immunesciences, Inc. Therapeutic apheresis
DE3310727A1 (de) * 1983-03-24 1984-10-04 B. Braun Melsungen Ag, 3508 Melsungen Verfahren und vorrichtung zur selektiven, extrakorporalen abtrennung pathologischer und/oder toxischer blutbestandteile
JPS6058915A (ja) * 1983-09-12 1985-04-05 Fujisawa Pharmaceut Co Ltd 薬物含有脂質小胞体製剤
US5622713A (en) * 1985-09-17 1997-04-22 The Regents Of The University Of California Method of detoxifying animal suffering from overdose
US4751244A (en) * 1986-04-04 1988-06-14 Merck & Co., Inc. Compounds useful in treating sickle cell anemia
GB2232984B (en) * 1986-08-19 1991-05-08 Showa Denko Kk Method of adsorbing immunoglobulin by using porous beads of chitosan
US5128318A (en) * 1987-05-20 1992-07-07 The Rogosin Institute Reconstituted HDL particles and uses thereof
AU633488B2 (en) * 1988-04-04 1993-02-04 Northwestern University Binding of immune complexes by modified forms of c-reactive protein
IL91664A (en) * 1988-09-28 1993-05-13 Yissum Res Dev Co Ammonium transmembrane gradient system for efficient loading of liposomes with amphipathic drugs and their controlled release
FR2645866B1 (fr) * 1989-04-17 1991-07-05 Centre Nat Rech Scient Nouvelles lipopolyamines, leur preparation et leur emploi
US5542935A (en) * 1989-12-22 1996-08-06 Imarx Pharmaceutical Corp. Therapeutic delivery systems related applications
US5371186A (en) * 1991-02-11 1994-12-06 Biosynth S.R.L. Synthetic peptides for detoxification of bacterial endotoxins and for the prevention and treatment of septic shock
US5261876A (en) * 1992-06-12 1993-11-16 Moncrief-Popovich Research Institute, Inc. Enhanced peritoneal membrane plasmapheresis
US6139871A (en) * 1995-07-26 2000-10-31 The University Of British Columbia Liposome compositions and methods for the treatment of atherosclerosis
US5746223A (en) * 1996-10-11 1998-05-05 Williams; Kevin Jon Method of forcing the reverse transport of cholesterol from a body part to the liver while avoiding harmful disruptions of hepatic cholesterol homeostasis
US6028103A (en) * 1994-09-16 2000-02-22 Children's Medical Center Corporation Triaryl methane compounds and analogues thereof useful for the treatment or prevention of sickle cell disease or diseases characterized by abnormal cell proliferation
US5958901A (en) * 1995-06-07 1999-09-28 Genta Incorporated Phosphonic acid-based cationic lipids
JPH11510489A (ja) * 1995-07-21 1999-09-14 ジンタ・インコーポレイテッド 新規アミド基本カチオン性脂質
US5948756A (en) * 1995-08-31 1999-09-07 Yissum Research Development Company Of The Hebrew University Of Jerusalem Therapeutic lipoprotein compositions
CA2231547A1 (en) * 1995-10-11 1997-04-17 Kevin Jon Williams Liposomal compositions and methods of using them
US5827533A (en) * 1997-02-06 1998-10-27 Duke University Liposomes containing active agents aggregated with lipid surfactants
US6120751A (en) * 1997-03-21 2000-09-19 Imarx Pharmaceutical Corp. Charged lipids and uses for the same
US5998593A (en) * 1998-03-10 1999-12-07 Abbott Laboratories Fluorescent enzyme substrates
US20020086276A1 (en) * 2000-12-28 2002-07-04 Srivastava Pramod K. Immunotherapeutic methods for extracorporeal modulation of CD36 and its ligands

Also Published As

Publication number Publication date
EP1372758B1 (de) 2008-07-09
CA2443237A1 (en) 2002-10-17
DE50212473D1 (de) 2008-08-21
US20040115278A1 (en) 2004-06-17
DE10117043A1 (de) 2002-11-07
WO2002081006A1 (de) 2002-10-17
CA2443237C (en) 2011-08-02
US20080096185A1 (en) 2008-04-24
EP1372758A1 (de) 2004-01-02

Similar Documents

Publication Publication Date Title
ATE400309T1 (de) Verfahren zur eliminierung von potentiell toxischen und/oder schädlichen stoffen
DE60219074D1 (de) Mehrstufige vorrichtung und verfahren zur trennung von fluiden
DE60206052D1 (de) System und verfahren zur bearbeitung von flugplandaten
EP1623227A4 (de) Proteine, sensoren und verfahren zur charakterisierung von analyten damit
DE602004026158D1 (de) Funktionelle sphärische Partikel, Methoden und Apparate zur Unterscheidung derselben
DE60234439D1 (de) Stent zur ableitung von körperflüssigkeiten
DE60232846D1 (de) Vorrichtung, Computerprogramm und Verfahren zur Kommunikationsnavigation
DE50210047D1 (de) System und verfahren zur modellierung und/oder realisierung von softwareanwendungen, insbesondere mes-anwendungen
DE60237007D1 (de) Verfahren und vorrichtung zur kurzfristigen inspekrobustheit
DE602004029853D1 (de) Vorrichtung und Verfahren zur Aufbereitung von Proben
DE60204043D1 (de) Vorrichtung und verfahren zur abscheidung von atomaren schichten
EP1611435A4 (de) Verfahren und vorrichtung zur kennzeichnung von mehrphasen-fluidgemischen
DE50203544D1 (de) Verfahren und Vorrichtung zur Drehbearbeitung
DE60212041D1 (de) Verfahren und Vorrichtung zur Entfernung von Quecksilber
DE112004001110D2 (de) System und Verfahren zur Bearbeitung von Werteinheiten
ATE362530T1 (de) Verfahren und vorrichtung zur reinigung von nukleinsäuren
DE60229204D1 (de) Prozessor und Verfahren zur Urladung desselben
DE50214217D1 (de) Verfahren zur ermittlung des ladezustands und/oder
DE602004016712D1 (de) Vorrichtung und Verfahren zur Bestimmung von Blutkomponenten
DE50214806D1 (de) Verfahren und vorrichtung zur abgasnachbehandlung
EP1623183A4 (de) System und verfahren für die behandlung von gefahrstoffen, z. b. nicht explodierter munition in der chemischen kriegsführung
DE60209541D1 (de) Verfahren zur herstellung von sekundären und tertiären aminofunktionellensilanen, iminoorganosilanen und/oder imidoorganosilanen
DE60219580D1 (de) Verfahren und Vorrichtung zur Plasmabearbeitung
DE50200950D1 (de) Vorrichtung und Verfahren zur Erstellung und/oder Änderung von NC-Programmen oder NC-Tabellen
CH695428A5 (de) Verfahren und Vorrichtung zur Entschärfung von Munition.